BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News » Publication » Apolipoprotein CIII hyperactivates insulin producing beta cells

Apolipoprotein CIII hyperactivates insulin producing beta cells

Signal transduction between the diabetogenic blood factor apolipoprotein CIII (apoCIII) and insulin-producing beta cells is now clarified. ApoCIII acts upon the calcium channels through kinases PKA and Src, involving a receptor SR-BI and an integrin beta1. The results are published in Cellular and Molecular Life Sciences on the 15th of August 2013.  

Calcium is very important for a normal function of insulin-secreting beta-cells. Calcium is transported into the and out of the cells via calcium channels. Serum factor apoCIII has been identified as a cause for increased activity of these channels, leading to higher concentration of calcium and subsequently beta-cell death. So far, the signal transduction mechanism of this action has remained unknown.

Researchers in Professor P-O Berggren’s group at Karolinska Institutet have now clarified the signal transduction pathway. A joint action of beta1 integrin and SR-BI receptors, sitting in the beta-cell membrane, is needed to convey the apoCIII stimulation to the PKA and Prs kinases. A parallel activation of these kinases inside the beta cell keeps the calcium channels open and functional for a longer time.

Discovery of this molecular pathway opens opportunities for development of novel drugs for prevention of beta-cell death and development of diabetes. The results are published in Cellular and Molecular Life Sciences on the 15th of August 2013.

Read more:

Apolipoprotein CIII hyperactivates β cell CaV1 channels through SR-BI/β1 integrin-dependent coactivation of PKA and Src. Shi Y, Yang G, Yu J, Yu L, Westenbroek R, Catterall WA, Juntti-Berggren L, Berggren PO, Yang SN. Cell Mol Life Sci. 2013 Aug 15

November 26, 2013 Catharina Rahm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications February 6, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024
  • Årsstämma 16 juni 2023
    Årsstämma 16 juni 2023 May 29, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved